Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06386029 · ClinicalTrials.gov registry record · NA
The Power Down Pilot Study: A Novel Bedtime Manipulation Protocol
A NA study of Autism and Sleep Disturbance, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT06386029: Recruiting NA study of Autism and Sleep Disturbance, sponsored by University of Pittsburgh.
NCT06386029 is a NA study of Autism and Sleep Disturbance that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 10 participants, below the 183-participant average among 104 other Autism trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06386029, a NA study of Autism and Sleep Disturbance, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this pilot intervention study is to examine the feasibility and acceptability of a novel bedtime manipulation protocol called "The Power Down" for autistic youth, ages 6-10. The main questions it aims to answer are: 1. Is the Power Down feasible for caregivers to do each night? 2. Do the families find the Power Down an acceptable intervention to address their child's difficulties settling down to fall asleep?
Primary Outcome
We will use recruitment rates as one of our primary measure of feasibility of this protocol. Benchmark include: Recruitment rates: \>2 caregiver-child dyads enrolled per month
Conditions Studied
Interventions
- BEHAVIORAL Power Down bedtime manipulation
Study Locations (1)
Pennsylvania
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-07-05 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT06386029 shows while recruiting
NCT06386029 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 183-participant average among 104 other Autism trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with Autism appearing as the primary indexed condition, and to 1 intervention - of which Power Down bedtime manipulation is the first listed.
NCT06386029 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06386029 about?
NCT06386029 is a clinical study titled "The Power Down Pilot Study: A Novel Bedtime Manipulation Protocol". The goal of this pilot intervention study is to examine the feasibility and acceptability of a novel bedtime manipulation protocol called "The Power Down" for autistic youth, ages 6-10. The main questions it aims to answer are: 1. Is the Power Down feasible for caregivers to do each night? 2. Do th...
What is the current status of trial NCT06386029?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2025-07-05. Estimated completion is 2026-12.
What conditions does trial NCT06386029 study?
This clinical trial studies the following conditions: Autism, Sleep Disturbance.
What interventions are being tested in trial NCT06386029?
The interventions under investigation include: Power Down bedtime manipulation (BEHAVIORAL).
Who is sponsoring clinical trial NCT06386029?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06386029 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06386029's enrollment target sits among peer trials
10 102nd of 104 higher than 2 of 104 other Autism trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Autism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Online Pivotal Response Treatment Training in Autism Spectrum Disorder
RECRUITING · NA
-
Cerebellum and Autism: Regional Specialization for Social and Executive Functions
RECRUITING · NA
-
Modified Pivotal Response Treatment for Insistence on Sameness in Autistic Youth
RECRUITING · NA
-
Examining the Effectiveness of the Early Start Denver Model in Community Programs Serving Young Autism
RECRUITING · NA
-
Evaluating Pathways Mutual Gaze Protocol on Social Skills in Young Children Suspected of Autism
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI